DNMT3A and viral infectious disease: Using the methyltransferase inhibitor Decitabine, we demonstrate that transient inhibition of Dnmt3a activity early during T cell priming reduces memory Th1 cell lineage commitment while also improving Tfh cell functionality to primary and secondary viral infections, representing a novel approach to enhance germinal center responses.